Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...
Read MoreVANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 ...
Read MoreLONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...
Read MoreRnRMarketResearch.com adds "Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2015" to its store. The report provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD)'s therapeutic pipeline. DALLAS , Aug. ...
Read MoreMORGANTOWN, W.Va. , Aug. 4, 2015 /PRNewswire/ -- For many, summer and swimming are synonymous. From swimming pools, hot tubs and spray parks to rivers and lakes, each year warmer temperatures send millions of Americans in search of a refreshing ...
Read MorePRINCETON, N.J. , Aug. 4, 2015 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and ...
Read MoreContinues Endo's Transformation into a Leading Global Specialty Pharmaceutical Company DUBLIN , Aug. 4, 2015 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the completion of the previously announced sale ...
Read More$27.5 million in Financing Drives Social Impact and Job Creation for Underserved Residents Across Seven States ARLINGTON, Va. , Aug. 4, 2015 /PRNewswire-USNewswire/ -- Capital Impact Partners announced today that it provided nearly $27.5 ...
Read MorePARSIPPANY, N.J. , Aug. 3, 2015 /PRNewswire/ -- LEO Pharma supports the recent decision by the U.S. Food and Drug Administration (FDA) to include psoriasis as one of eight priority disease areas in its 2016-2017 Patient Focused Drug ...
Read MoreZander Oncology Platform includes immunotherapy, small molecule, gene silencing and cancer stem cell targeting for Canine Cancer and Feline Leukemia SAN DIEGO , August 3, 2015 /PRNewswire/ -- Zander Therapeutics, a wholly owned ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers